Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

21. Dezember 2022 07:45 ET | Quelle: Umbra Applied Technologies Group, Inc.

UAT Group’s Subsidiary, H2O Processing, Enters into Agreement to Acquire Discharge Well Interest Valued at $2.8M Annually

Denver, CO, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Umbra Applied Technologies Group, Inc’s (OTC Pink: UATG) subsidiary, H2O Processing, announced today that it has entered into an agreement with Bellows...
20. Dezember 2022 19:01 ET | Quelle: Sosei Group Corporation

Sosei Heptares' Partner Pfizer Progresses its Oral GLP-1 Receptor Agonist PF-07081532 into Phase 2 Clinical Trials for Treating Type 2 Diabetes and Obesity

PF-07081532 is the first clinical candidate from multi-target drug discovery collaboration to advance into Phase 2 trialsDosing of first subject in Phase 2 trial by Pfizer triggers payment of US$10...
20. Dezember 2022 11:36 ET | Quelle: Kymanox

Mathias Romacker Selected as the Newest Member of the Kymanox Executive Advisor Team

Los Angeles, California, USA and Research Triangle Park, North Carolina, USA, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Kymanox Corporation (“Kymanox”), a professional services organization supporting...
20. Dezember 2022 01:30 ET | Quelle: Sosei Group Corporation

Sosei Heptares to present at 41st Annual J.P. Morgan Healthcare Conference

TOKYO and CAMBRIDGE, United Kingdom, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Sosei Group Corporation (“the Company”; TSE: 4565) announces its President & CEO Chris Cargill will present at the 41st...
19. Dezember 2022 16:05 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics Appoints Drs. Peter Atadja and Trafford Clarke to its Board of Directors

NEWTOWN, Pa., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
19. Dezember 2022 12:00 ET | Quelle: Zhittya Genesis Medicine Inc

Zhittya Genesis Medicine announces: Free Zoom Webinar: Zhittya Parkinson’s Disease Research Study: 6-Month Patient Follow-Up Report

LAS VEGAS, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that they will be hosting a webinar on Tuesday, December 20, 2022, at 4:00 PM...
19. Dezember 2022 07:00 ET | Quelle: Madrigal Pharmaceuticals, Inc.

Madrigal Announces Positive Topline Results from the Pivotal Phase 3 MAESTRO-NASH Clinical Trial of Resmetirom for the Treatment of NASH and Liver Fibrosis

In MAESTRO-NASH, a 52-week serial liver biopsy Phase 3 study in more than 950 patients, resmetirom achieved both primary endpoints and potentially clinically meaningful effects with both daily oral...
19. Dezember 2022 06:48 ET | Quelle: Research and Markets

Single Cell Technology Competitive Landscape Report 2022: 100+ New Technologies in SCT Fields Including 37+ Pre-commerce Stage Startups and a Complete List of Spatial Analysis Players

Dublin, Dec. 19, 2022 (GLOBE NEWSWIRE) -- The "Comprehensive Single Cell Technology 2022" report has been added to ResearchAndMarkets.com's offering. The market size is ~ $0.86 billion USD in...
18. Dezember 2022 16:00 ET | Quelle: Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals To Announce Topline Results from the Phase 3 MAESTRO-NASH Study of Resmetirom on Monday, December 19th

CONSHOHOCKEN, Pa., Dec. 18, 2022 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic...
16. Dezember 2022 08:48 ET | Quelle: BiondVax Pharmaceuticals Ltd.

BiondVax Announces Pricing of $8 Million Underwritten Public Offering

JERUSALEM, Dec. 16, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) (“Company”), which focuses on developing, manufacturing, and commercializing innovative...

Vorherige Seite

Nächste Seite